United States
Germany
Japan
United Kingdom
China
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI8E9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Antibodies
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI3D7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI6A12
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI6A12
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI8E9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI3D7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI6A12
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI8E9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI3D7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
